Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-21-035684

Chief Financial Officer bought 5,885 shares at $8.48 ($49,925)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Silver Brian M. Chief Financial Officer 2021-09-09 Purchase +5,885 $8.48 $49,925 6,885 D
Open-market purchases · 5,885 sh · avg $8.48 · $49,925
Loading xslF345X03/doc4.xml…